Raised serum proinflammatory cytokines in Alzheimer's disease with depression

Aging and Disease

Volumn 5, Issue 3, 2014, Pages 170-176

  Khemka, Vineet Kumar ^a   Ganguly, Anirban ^a   Bagchi, Debajit ^a   Ghosh, Arindam ^a   Bir, Aritri ^a   Biswas, Atanu ^b   Chattopadhyay, Sita ^a   Chakrabarti, Sasanka ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b BANGUR INSTITUTE OF NEUROSCIENCES   (India)

Author keywords

Alzheimer's disease; Cognitive deficit; Depression; IL 1 ; IL 6; TNF

Indexed keywords

EID: 84914705872     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500170     Document Type: Article

References (31)

1. Qiu C, Fratiglioni L (2011). Epidemiology of dementia. In: Mcnamara P ed. Dementia Treatments and Developments. ABC-CLIO, 1-33.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7: 263-269.
3. Starkstein SE, Mizrahi R. Depression in Alzheimer's disease (2006). Expert Rev Neurother, 6: 887-895.
4. Alvarez XA, Franco A, Fernandez-Novoa L, Cacabelos R (1996). Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease. Mol Chem Neuropathol, 29: 237-252.
5. Gezen-Ak D, Dursun E, Hanagasi H, Bilgiç B, Lohman E, Araz OS, et al (2013). BDNF, TNFa, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment. J Alzheimers Dis, 37:185-195.
6. Humpel C, Hochstrasser T (2011). Cerebrospinal fluid and blood biomarkers in Alzheimer's disease. World J Psychiatry, 1: 8-18.
7. Swardfager W, Lanctot K, Rothenburg L, Wong A, Capell J, Hermann NA (2010). Meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry, 68: 930-941.
8. Leonard BE (2007). Inflammation, depression and dementia: are they connected? Neurochem Res, 32: 1749-1756.
9. Anisman H (2009). Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci, 34: 4-20.
10. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009). A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsycho pharmacol, 12: 561-578.
11. Kronfol Z, Remick DG (2000). Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry, 157: 683-694.
12. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 9: 46-56.
13. Terrando N, Monaco C, Ma D, Foxwell BM, Feldmann M, Maze M (2010). Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A, 107: 20518-20522.
14. Wilson CJ, Finch CE, Cohen HJ (2002). Cytokines and cognition -The case for head-to-toe inflammatory paradigm. J Am Geriatr Soc, 50: 2041-2056.
15. McAfoose J, Baune BT (2009). Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev, 33: 355-366.
16. Lim A, Krajina K, Marsland AL (2013). Peripheral inflammation and cognitive aging. Mod Trends Pharmacopsychiatry, 28: 175-187.
17. Cameron B, Landreth GE (2010). Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis, 37: 503-509.
18. Weisman D, Hakimian E, Ho GJ (2006). Interleukins, Inflammation, and Mechanisms of Alzheimer's Disease. Vitam Horm, 74: 505-530.
19. Weitz TM, Town T (2012). Microglia in Alzheimer's Disease: It's All About Context. Int J Alzheimers Dis, 2012:314185.
20. Mrak RE, Griffin WS (2005). Potential inflammatory biomarkers in Alzheimer's disease. J Alzheimer's Dis, 8: 369-375.
21. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, Hong CH (2009). Peripheral cytokines and chemokines in Alzheimer's disease. Dement Geriatr Cogn Disord, 28:281-287.
22. Barrientos RM, Frank MG, Watkins LR, Maier SF (2010). Memory Impairments in Healthy Aging: Role of Aging-Induced Microglial Sensitization. Aging Dis, 1: 212-231.
23. Maier SF (2003). Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun, 17: 69-85.
24. Makhija K, Karunakaran S (2013). The role of inflammatory cytokines on the aetiopathogenesis of depression. Aust N Z J Psychiatry, 47: 828-839.
25. Cyranowski JM, Marsland AL, Bromberger JT, WhitesideTL, Chang Y, Matthews KA (2007). Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun, 21: 229-237.
26. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al (2003). Depression as a risk factor for Alzheimer disease -The MIRAGE study. Arch Neurol, 60: 753-759.
27. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JCS (1997). A twin study of late-onset depression and apolipoprotein E e4 as risk factors for Alzheimer's disease. Biol Psychiatry, 41: 851-856.
28. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Yakov S, Mayeux R (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry, 53: 175-182.
29. Cacquevel M, Lebeurrier N, Cheenne S, Vivien D (2004). Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets, 5: 529-534.
30. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B (1999). TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides, and decrease the secretion of APPs. FASEB J, 13: 63-68.
31. Smith JA, Das A, Ray SK, Banika NL (2010). Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Research Bulletin, 87: 10-20.